Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis

Naoki Miyazaki,Toshiki Iwasaki,Hitomi Sakai,Rurina Watanuki,Yoshinori Tanizawa,Zhihong Cai,Tsutomu Kawaguchi,Junji Tsurutani,Kengo Nagashima
DOI: https://doi.org/10.1080/03007995.2024.2332436
2024-04-12
Current Medical Research and Opinion
Abstract:Background The clinicopathological factors indicating risk of recurrence are used to guide the choice of perioperative therapy in patients with breast cancer. Although several risk factors for recurrence have been reported in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) early breast cancer in Japan, there has been no systematic review quantifying potential risk factors.
medicine, general & internal, research & experimental
What problem does this paper attempt to address?